Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Autolus Therapeutics (AUTL) Debt to Equity (2017 - 2018)

Autolus Therapeutics (AUTL) has disclosed Debt to Equity for 2 consecutive years, with $0.0 as the latest value for Q3 2018.

  • For the quarter ending Q3 2018, Debt to Equity fell 72.2% year-over-year to $0.0, compared with a TTM value of $0.0 through Sep 2018, down 72.2%, and an annual FY2018 reading of $0.0, down 72.2% over the prior year.
  • Debt to Equity was $0.0 for Q3 2018 at Autolus Therapeutics, down from $0.01 in the prior quarter.
  • Across five years, Debt to Equity topped out at $0.01 in Q3 2017 and bottomed at $0.0 in Q3 2018.